Clinical Trials on Adrenal Cancer in China

Total 8073 results

Chinese Academy of Medical Sciences, Fuwai Hospital

Recruiting

Antecubital Versus Femoral Approach for Adrenal Venous Sampling (AFAVS)

Hyperaldosteronism

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown

Deep Learning Magnetic Resonance Imaging Radiomic Predict Platinum-sensitive in Patients With Epithelial Ovarian Cancer

Predictive Cancer Model

China
Wang Xinying
Xijing Hospital; Peking Union Medical College Hospital; Chinese PLA General Hospital and other collaborators

Completed

A Novel Nomogram to Predict the Postoperative Overall Survival in Gastrointestinal Cancer Patients

Prognosis | Nutrition Assessment | Gastrointestinal Cancers - Stomach | Gastrointestinal Cancers - Colorectal | Survival Analysis

China
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

Advanced Kidney Cancer

China
Dragonboat Biopharmaceutical Company Limited
Fudan University

Recruiting

the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors

Bladder Cancer | Renal Carcinoma | Advanced Penile Carcinoma

China
Sun Yat-sen University

Unknown

A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study (GITIC)

Gastrointestinal Cancers

China
Novartis Pharmaceuticals

Completed

Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer

Metastatic Renal Cell Carcinoma

China
Peking University Cancer Hospital & Institute

Recruiting

KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade

Digestive System Cancers

China
Peking University Third Hospital

Recruiting

The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy (ONFM-SBRT)

Renal Cell Carcinoma | Pancreatic Cancer | Lung Cancer | Liver Cancer

China
Shanghai Gynecologic Oncology Group
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Obstetrics... and other collaborators

Not yet recruiting

Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Carcinoma

China
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

Ovarian Epithelial Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

China
Shanghai East Hospital
Anhui Provincial Hospital; Nanjing Legend Biotech Co.; East Clinical Center of...

Terminated

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-M23, a CAR-T Cell Therapy Targeting MSLN in Patients With Relapsed and Refractory Epithelial Ovarian Cancer

Epithelial Ovarian Cancer

China
Jun Zhang

Completed

Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer

Advanced Ovarian Cancer

China
RenJi Hospital

Completed

Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer. (ctDNA_EOC)

Epithelial Ovarian Cancer

China
Beihua Kong
Sun Yat-sen University; Huazhong University of Science and Technology; Zhejiang...

Recruiting

TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors (MOGCT-01)

Ovarian Neoplasms | Ovarian Cancer | Ovarian Germ Cell Cancer

China
Qifu Li
Xiangya Hospital of Central South University; West China Hospital; Tongji Hospital and other collaborators

Recruiting

Outcome of 68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism (GAPA)

Primary Aldosteronism

China
Xiao Chen

Recruiting

CXCR4 Targeted PET Imaging in the Diagnosis and Identification of Primary Aldosteronism

Primary Aldosteronism

China
Chongqing Medical University

Completed

Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism(ADOPA)

Primary Aldosteronism

China
Qifu Li
The Affiliated Hospital Of Southwest Medical University

Completed

68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism

Primary Aldosteronism

China
Chongqing Medical University

Completed

Comparison of Three Confirmatory Tests in the Diagnosis of Primary Aldosteronism

Primary Aldosteronism

China
Chongqing Medical University

Completed

Diagnostic Accuracy of Seated Saline Suppression Test for Primary Aldosteronism

Primary Aldosteronism

China
Changhai Hospital

Not yet recruiting

Urine DNA Methylation Detection for Hematuria Evaluation

Bladder Cancer | Urothelial Carcinoma | Ureter Cancer | Hematuria | Renal Pelvis Cancer

China
Peking Union Medical College Hospital

Unknown

68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings

Epithelial Ovarian Cancer

China
Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Recruiting

Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer

Advanced Ovarian Cancer

China
Telix International Pty Ltd
Grand Pharmaceutical (China) Co., Ltd.

Completed

Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma (ZIRDOSE-CP)

Clear Cell Renal Cell Carcinoma | Recurrent Renal Cell Cancer | Suspected Recurrent Renal Clear Cell Carcinoma

China
Shanghai Jiao Tong University School of Medicine

Not yet recruiting

Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism (FAVOR)

Primary Aldosteronism

China
Shanghai Zhongshan Hospital

Completed

AVS After 1mg DST to Determine Subtype in PA

Primary Aldosteronism

China
Qifu Li
Second Affiliated Hospital, School of Medicine, Zhejiang University; The First... and other collaborators

Recruiting

Finerenone for Patients With Primary Aldosteronism (FAIRY)

Primary Aldosteronism

China
Chongqing Medical University
Chinese PLA General Hospital; Tianjin Medical University General Hospital; Chinese...

Recruiting

Primary Aldosteronism LC-MS/MS-specific Cutoffs (PM)

Primary Aldosteronism

China
Chongqing Medical University

Recruiting

Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism

Primary Aldosteronism

China
Shanghai Jiao Tong University School of Medicine

Not yet recruiting

Primary Aldosteronism: Prospective Screening Registry in China

Primary Aldosteronism

China
Chongqing Medical University

Recruiting

Chongqing Primary Aldosteronism Study

Primary Aldosteronism

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostatic Cancer

China
Chinese PLA General Hospital

Completed

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Brain Tumor | Liver Cancer | Ovarian Tumor | Acute Myeloid and Lymphoid Leukemias

China
Xinhua Hospital, Shanghai Jiao Tong University...

Withdrawn

Oral Topotecan Combined With Anlotinib in Patients With Platinum-resistant Recurrent Ovarian Cancer

Platinum-resistant Ovarian Cancer

China
Sun Yat-sen University
Hutchmed

Recruiting

Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer

Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer | Ovarian Carcinoma | Fallopian Tube Carcinosarcoma

China
Jiangsu HengRui Medicine Co., Ltd.
Peking University Cancer Hospital & Institute

Completed

A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients

Ovarian Cancer | Triple Negative Breast Cancer

China
Hansoh BioMedical R&D Company

Recruiting

HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer

Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal Cancer

China
Fudan University

Not yet recruiting

The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab

Recurrent Ovarian Cancer

China
Huabo Biopharm Co., Ltd.

Recruiting

A Study of HB0025 Injection in Patients With Advanced Renal Cancer

Renal Cancer

China
The Affiliated Hospital of the Chinese Academy...

Recruiting

Microtransplantation for Ovarian Cancer

Ovarian Cancer Recurrent

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients

Relapsed Ovarian Cancer

China
Shu-Zhong Cui
Xiangya Hospital of Central South University; Wuhan University; Peking University... and other collaborators

Unknown

Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer (EHNPCTASEOC)

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Carcinoma

China
Women's Hospital School Of Medicine Zhejiang University

Active, not recruiting

Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer

Efficacy and Safety

China
Qianfoshan Hospital
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Unknown

Camrelizumab Combined With Apatinib in the Treatment of Epithelial Ovarian Cancer

Immune Checkpoint Inhibition

China
Shanghai Gynecologic Oncology Group
Fudan University

Not yet recruiting

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Carcinoma

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Not yet recruiting

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Urothelial Carcinoma | Metastatic Castration-resistant Prostate Cancer | Clear Cell Renal Carcinoma

China
First Affiliated Hospital of Chengdu Medical College

Not yet recruiting

The Long-term Effect of SAAE and Medical Treatment for Primary Aldosteronism

Primary Aldosteronism

China
Lei Li

Unknown

A Training Set for the HRD Model in EOC

Epithelial Ovarian Cancer | Homologous Recombination Deficiency | Prognosis | BRCA Mutation | Loss of Heterozygosity | Platinum Resistance

China
Ruijin Hospital

Unknown

Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation

Ovarian Cancer | Endometrial Cancer

China

Clinical Trials on Adrenal Cancer in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations